Clinical and forensic aspects of postpartum disorders

Journal of the American Academy of Psychiatry and the Law

Volumn 29, Issue 3, 2001, Pages 344-347

  Gold, L H ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CHILD ABUSE; CLINICAL FEATURE; DELUSION; FORENSIC PSYCHIATRY; HUMAN; NEGLECT; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; RECURRENT DISEASE; SHORT SURVEY; SUICIDE ATTEMPT;

ANTIDEPRESSIVE AGENTS; DEPRESSION, POSTPARTUM; FEMALE; FORENSIC PSYCHIATRY; HUMANS; INFANT; INFANT, NEWBORN; INFANTICIDE; PREGNANCY; PSYCHOTIC DISORDERS; RECURRENCE; SUICIDE; TEXAS; UNITED STATES;

EID: 0034785260     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (40)

1. Mood disorders during pregnancy and lactation: Defining issues of exposure and treatment
2. Course of mood and anxiety disorders during pregnancy and the postpartum period
3. Pharmacologic management of psychiatric illness during pregnancy and the postpartum period
4. Postpartum mood disorders
5. Maternal depression and comorbidity: Predicting early parenting, attachment security, and toddler social-emotional problems and competencies
6. The effects of postpartum depression on child development: A meta-analysis
7. Postpartum depression and child development
8. Depression and the parenting of young children: Making the case for early preventive mental health services
9. Antidepressant treatment during breastfeeding
10. Prevention of recurrent postpartum depression: A randomized clinical trial
11. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines
12. A randomized trial of relapse prevention of depression in primary care
13. Depression during pregnancy and the puerperium
14. Psychopharmacology during pregnancy and lactation
15. Prevention of recurrent postpartum depression: A randomized clinical trial
16. Postpartum and nonpostpartum depression: Differences in presentation and response to pharmacologic treatment
17. Risk-benefit decision making for treatment of depression during pregnancy
18. Use of psychotropic medications during pregnancy: Risk management guidelines
19. The use of psychotropic medications during breast-feeding
20. Birth outcomes in pregnant women taking fluoxetine
21. Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series
22. Birth outcomes following prenatal exposure to fluoxetine
23. Delivery outcome after the use of antidepressants in early pregnancy
24. Psychotropic guidelines for breastfeeding mothers
25. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study
26. Psychotropic medications in lactation
27. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants: A collaborative study of the European Network of Teratology Information Services (ENTIS)
28. Neurodevelopment of children exposed in utero to antidepressant drugs
29. Psychopharmacological treatment during pregnancy and lactation
30. Breastfeeding and women's health
31. Rates and risk of postpartum depression: A meta-analysis
32. Mothers who killed or attempted to kill their child: Life circumstances, childhood abuse, and types of killing
33. Postpartum mood disorders: Clinical perspectives
34. Murder of the newborn: A psychiatric review of neonaticide
35. Women who kill their children
36. Mothers who kill their children